OPRM1 cohort
Evidence from:
primary |
all sources
Related entities (181)
Mentioned in (60)
Papers in which this entity is mentioned.
- Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals. (2023)
- Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond. (2022)
- Transcriptional and anatomical diversity of medium spiny neurons in the primate striatum. (2021)
- Genetics of substance use disorders in the era of big data. (2021)
- Genome-wide association analysis of opioid use disorder: A novel approach using clinical data. (2020)
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- Effects of chronic intermittent ethanol exposure and withdrawal on neuroblastoma cell transcriptome. (2020)
- Differential sensitivity of human neurons carrying μ opioid receptor (MOR) N40D variants in response to ethanol. (2020)
- Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction. (2019)
- A review on neuroimaging studies of genetic and environmental influences on early brain development. (2019)
- Epigenetic mechanisms in alcohol- and adversity-induced developmental origins of neurobehavioral functioning. (2018)
- Human Genetics of Addiction: New Insights and Future Directions. (2018)
- An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors. (2017)
- Genetic studies of alcohol dependence in the context of the addiction cycle. (2017)
- Review: Pharmacogenetics of alcoholism treatment: Implications of ethnic diversity. (2017)
- KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. (2016)
- Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (2015)
- Alcohol Dependence Genetics: Lessons Learned From Genome-Wide Association Studies (GWAS) and Post-GWAS Analyses. (2015)
- Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure. (2015)
- Clinically relevant genetic biomarkers from the brain in alcoholism with representation on high resolution chromosome ideograms. (2015)
- Gene expression in the addicted brain. (2014)
- Pharmacogenetics of OPRM1. (2014)
- Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G. (2014)
- Genome-wide association discoveries of alcohol dependence. (2014)
- The impact of exposure to addictive drugs on future generations: Physiological and behavioral effects. (2014)
- Combined analysis of circulating β-endorphin with gene polymorphisms in OPRM1, CACNAD2 and ABCB1 reveals correlation with pain, opioid sensitivity and opioid-related side effects. (2013)
- Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents. (2013)
- Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (2013)
- Synaptic effects induced by alcohol. (2013)
- Stress-related neuropeptides and addictive behaviors: beyond the usual suspects. (2012)
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012)
- The genetics of alcohol dependence: advancing towards systems-based approaches. (2012)
- Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. (2012)
- The genetic basis of alcoholism: multiple phenotypes, many genes, complex networks. (2012)
- The genetic basis of addictive disorders. (2012)
- Maternal immune activation yields offspring displaying mouse versions of the three core symptoms of autism. (2012)
- Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence. (2012)
- The genetics of the opioid system and specific drug addictions. (2012)
- Meta-analysis and genome-wide interpretation of genetic susceptibility to drug addiction. (2011)
- A genetic determinant of the striatal dopamine response to alcohol in men. (2011)
- Haplotype block structure of the genomic region of the mu opioid receptor gene. (2011)
- AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. (2011)
- Pharmacological treatment of cannabis dependence. (2011)
- Transcriptional and epigenetic mechanisms of addiction. (2011)
- Molecular assays for characterization of alternatively spliced isoforms of the u opioid receptor (MOR). (2010)
- Prenatal exposure to moderate levels of ethanol alters social behavior in adult rats: relationship to structural plasticity and immediate early gene expression in frontal cortex. (2010)
- Genome-wide scan for self-rating of the effects of alcohol in American Indians. (2010)
- Consilient research approaches in studying gene x environment interactions in alcohol research. (2010)
- Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. (2010)
- mu-Opioid receptor agonists differentially regulate the expression of miR-190 and NeuroD. (2010)
- Functional CRH variation increases stress-induced alcohol consumption in primates. (2009)
- Expansion of the human mu-opioid receptor gene architecture: novel functional variants. (2009)
- Nicotine withdrawal sensitivity, linkage to chr6q26, and association of OPRM1 SNPs in the SMOking in FAMilies (SMOFAM) sample. (2009)
- Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. (2009)
- Protein kinases and addiction. (2008)
- The incentive salience of alcohol: translating the effects of genetic variant in CNR1. (2008)
- Sexually dimorphic synaptic organization of the medial amygdala. (2005)
- Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain. (2001)
- Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. (1997)
- Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. (1996)
Merged raw entities (29)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| oprm1 | gene | 60 | 374 |
| human oprm1 | cohort | — | — |
| mopr | cohort | — | — |
| mop receptor | cohort | — | — |
| mor | cohort | — | — |
| mor-1 | cohort | — | — |
| mor-1k isoform | cohort | — | — |
| mor gene locus | cohort | — | — |
| mouse oprm1 | cohort | — | — |
| mu class opioid receptor | cohort | — | — |
| mu opioid receptor | cohort | — | — |
| mu-opioid receptor | cohort | — | — |
| mu opioid receptor gene | cohort | — | — |
| mu-opioid receptor gene | cohort | — | — |
| mu receptor | cohort | — | — |
| mu-receptor | cohort | — | — |
| opioid receptor mu 1 | cohort | — | — |
| oprm1 | cohort | — | — |
| oprm1 gene | cohort | — | — |
| oprm1 genotype | cohort | — | — |
| μ-opioid peptide receptor | cohort | — | — |
| μ-opioid peptide receptor gene | cohort | — | — |
| μ opioid receptor | cohort | — | — |
| μ-opioid receptor | cohort | — | — |
| µ opioid receptor | cohort | — | — |
| µ-opioid receptor | cohort | — | — |
| μ opioid receptor gene | cohort | — | — |
| μ-opioid receptor gene | cohort | — | — |
| μ-receptor gene | cohort | — | — |